Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Resistin: Insulin resistance to malignancy

(2015) Pilar Codoñer-Franch et al.   CLINICA CHIMICA ACTA

Association of Serum Levels of Adipokines and Insulin With Risk of Barrett's Esophagus: A Systematic Review and Meta-Analysis

(2015) Apoorva Krishna Chandar et al.   Clinical Gastroenterology and Hepatology

EAU Guidelines on Renal Cell Carcinoma: 2014 Update

(2015) Borje Ljungberg et al.   EUROPEAN UROLOGY

Screening strategies for colorectal cancer among patients with nonalcoholic fatty liver disease and family history

(2015) Martin C.S. Wong et al.   INTERNATIONAL JOURNAL OF CANCER

Metabolic risk score and cancer risk: pooled analysis of seven cohorts

(2015) Tanja Stocks et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity

(2015) Laetitia Delort et al.   LIFE SCIENCES

Adiposity and risk of thyroid cancer: a systematic review and meta-analysis

(2015) D. Schmid et al.   Obesity Reviews

Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander

(2015) Ester Vanni et al.   SEMINARS IN LIVER DISEASE

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 

(2014) B. Escudier et al.   ANNALS OF ONCOLOGY

Gut microbiota and obesity: Role in aetiology and potential therapeutic target

(2014) Carthage P. Moran et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Mechanisms behind the link between obesity and gastrointestinal cancers

(2014) Herbert Tilg et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Metabolic syndrome and breast cancer prognosis

(2014) Franco Berrino et al.   BREAST CANCER RESEARCH AND TREATMENT

Obesity and Cancer: A Gut Microbial Connection

(2014) N. Ohtani et al.   CANCER RESEARCH

Nonalcoholic fatty liver disease is a negative risk factor for prostate cancer recurrence

(2014) Won-Mook Choi et al.   ENDOCRINE-RELATED CANCER

Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study

(2014) Xian-Feng Lin et al.   MOLECULAR BIOLOGY REPORTS

The gut microbiota, bacterial metabolites and colorectal cancer

(2014) Petra Louis et al.   NATURE REVIEWS MICROBIOLOGY

Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion

(2014) Ana I. Pérez-Hernández et al.   Frontiers in Endocrinology

Leptine : implication dans la physiopathologie du cancer du sein

(2013) Florence Caldefie-Chézet et al.   ANNALES D ENDOCRINOLOGIE

Biochemical and molecular mechanisms for the association between obesity, chronic Inflammation, and breast cancer

(2013) David P. Rose et al.   BIOFACTORS

Central Adiposity Is Associated With Increased Risk of Esophageal Inflammation, Metaplasia, and Adenocarcinoma: A Systematic Review and Meta-analysis

(2013) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Circulating Inflammatory Cytokines and Adipokines Are Associated With Increased Risk of Barrett's Esophagus: A Case–Control Study

(2013) Jose M. Garcia et al.   Clinical Gastroenterology and Hepatology

Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy

(2013) K.-W. Huang et al.   Colorectal Disease

Associations of Diabetes Mellitus, Insulin, Leptin, and Ghrelin With Gastroesophageal Reflux and Barrett's Esophagus

(2013) Joel H. Rubenstein et al.   GASTROENTEROLOGY

Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium

(2013) Ai Kubo et al.   GUT

Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study

(2013) Hashem B El-Serag et al.   GUT

The Gordian Knot of dysbiosis, obesity and NAFLD

(2013) Wajahat Z. Mehal   Nature Reviews Gastroenterology & Hepatology

The role of obesity in gastrointestinal cancer: evidence and opinion

(2013) Claire L. Donohoe et al.   Therapeutic Advances in Gastroenterology

Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue

(2012) Stephen D. Hursting et al.   Annals of the New York Academy of Sciences

Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression

(2012) Candace A. Gilbert et al.   Annual Review of Medicine

Prostate Cancer and Metabolic Syndrome: Is there a link?

(2012) Donovan A. McGrowder et al.   Asian Pacific Journal of Cancer Prevention

Visceral adiposity in gastrointestinal and hepatic carcinogenesis

(2012) Roslyn Vongsuvanh et al.   CANCER LETTERS

Adipokines Linking Obesity with Colorectal Cancer Risk in Postmenopausal Women

(2012) G. Y. F. Ho et al.   CANCER RESEARCH

Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis

(2012) K. Esposito et al.   DIABETES CARE

Visceral Obesity and Risk of High Grade Disease in Clinical T1a Renal Cell Carcinoma

(2012) Yao Zhu et al.   JOURNAL OF UROLOGY

IGF-1 and Its Receptor in Esophageal Cancer: Association with Adenocarcinoma and Visceral Obesity

(2011) Suzanne L Doyle et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Metabolic syndrome and the risk of breast cancer in postmenopausal women

(2011) V. Rosato et al.   ANNALS OF ONCOLOGY

Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response meta-analysis of prospective studies

(2011) D. Aune et al.   ANNALS OF ONCOLOGY

Multifaceted link between cancer and inflammation

(2011) Gautam Sethi et al.   BIOSCIENCE REPORTS

The implication of adiponectin and resistin in gastrointestinal diseases

(2011) Elisavet K. Tiaka et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis

(2011) H. Endo et al.   GUT

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis

(2011) V. W.-S. Wong et al.   GUT

NAFLD and extrahepatic cancers: have a look at the colon

(2011) H. Tilg et al.   GUT

Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients

(2011) Yasuji Arase et al.   HEPATOLOGY RESEARCH

Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: A retrospective cohort study

(2011) Young In Lee et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort

(2011) Matthew J. Armstrong et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia

(2011) A. Stadlmayr et al.   JOURNAL OF INTERNAL MEDICINE

Diet-induced obesity elevates colonic TNF-α in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer

(2011) Zhenhua Liu et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway

(2011) A. Yadav et al.   MOLECULAR CANCER RESEARCH

Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease

(2011) Nadege T. Touzin et al.   Therapeutic Advances in Gastroenterology

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Association of visceral adiposity with oesophageal and junctional adenocarcinomas

(2010) P. Beddy et al.   BRITISH JOURNAL OF SURGERY

Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?

(2010) Paul Angulo   HEPATOLOGY

Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps

(2010) Sang Tae Hwang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Anthropometry and Esophageal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition

(2009) A. Steffen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Obesity and Cancer: The Role of Dysfunctional Adipose Tissue

(2009) R. C.M. van Kruijsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The role of resistin as a regulator of inflammation: Implications for various human pathologies

(2009) Mária Filková et al.   CLINICAL IMMUNOLOGY

Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver

(2009) G. Perseghin   DIABETES CARE

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice

(2009) Astrid Spruss et al.   HEPATOLOGY

Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case–control study

(2009) C. Agnoli et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives

(2009) A. Macciò et al.   Obesity Reviews

A Pilot Study of the Association of Low Plasma Adiponectin and Barrett's Esophagus

(2008) Joel H. Rubenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Barrett Esophagus

(2008) Aoife M. Ryan et al.   ANNALS OF SURGERY

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

(2008) Nila Rafiq et al.   Clinical Gastroenterology and Hepatology

Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways

(2008) Tamara Jaffe et al.   INTERNATIONAL JOURNAL OF CANCER

Decreased Serum Adiponectin Levels in Patients with Metastatic Renal Cell Carcinoma

(2008) A. Horiguchi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET

The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC)

(2008) Eleni M. Karapanagiotou et al.   LUNG CANCER